Have Your Say: Access to Palynziq for PKU

A potential new treatment for PKU — Palynziq — may soon be submitted to the PBAC (Pharmaceutical Benefits Advisory Committee) for government funding consideration.

We’re inviting the PKU community to join an important online Teams Meeting to help shape what access could look like if the submission goes ahead.

• Wednesday 18th June
• 8:00pm – 9:00pm AEDT
• Facilitated by Louise Healy

This session will focus on:
✔️ How MDDA is working with government and the sponsor
✔️ Understanding community needs and identifying those most likely to benefit
❌ Please note: This is not an education session on treatment suitability learn more about this treatment here  PKU Treatment Series: PALYNZIQ  

RSVP essential by 5pm Tuesday 17th June to: [email protected]